Cargando…
Gray/White Matter Contrast in Parkinson’s Disease
Gray/white matter contrast (GWC) decreases with aging and has been found to be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s disease (PD) patients has not been investigated. The aims of the study were to test whether GWC is sensitive to aging changes in PD patien...
Autores principales: | Uribe, Carme, Segura, Barbara, Baggio, Hugo C., Abos, Alexandra, Garcia-Diaz, Anna I., Campabadal, Anna, Marti, Maria J., Valldeoriola, Francesc, Compta, Yaroslau, Bargallo, Nuria, Junque, Carme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881246/ https://www.ncbi.nlm.nih.gov/pubmed/29636679 http://dx.doi.org/10.3389/fnagi.2018.00089 |
Ejemplares similares
-
Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018) -
Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson’s Disease
por: Garcia-Diaz, Anna Isabel, et al.
Publicado: (2017) -
Patterns of cortical thinning in nondemented Parkinson's disease patients
por: Uribe, Carme, et al.
Publicado: (2016) -
Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy
por: Abos, Alexandra, et al.
Publicado: (2019) -
Cortical Gray Matter and Hippocampal Atrophy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder
por: Campabadal, Anna, et al.
Publicado: (2019)